Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Liabilities (2016 - 2020)

Historic Total Liabilities for Monopar Therapeutics (MNPR) over the last 5 years, with Q3 2020 value amounting to $664468.0.

  • Monopar Therapeutics' Total Liabilities rose 3738.16% to $664468.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $664468.0, marking a year-over-year increase of 3738.16%. This contributed to the annual value of $724165.0 for FY2019, which is 8124.47% up from last year.
  • Monopar Therapeutics' Total Liabilities amounted to $664468.0 in Q3 2020, which was up 3738.16% from $648148.0 recorded in Q2 2020.
  • Monopar Therapeutics' 5-year Total Liabilities high stood at $724165.0 for Q4 2019, and its period low was $64510.0 during Q4 2016.
  • Over the past 5 years, Monopar Therapeutics' median Total Liabilities value was $443520.0 (recorded in 2020), while the average stood at $439515.8.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 38343.98% in 2017, then tumbled by 2352.92% in 2020.
  • Over the past 5 years, Monopar Therapeutics' Total Liabilities (Quarter) stood at $64510.0 in 2016, then skyrocketed by 383.44% to $311867.0 in 2017, then grew by 28.12% to $399551.0 in 2018, then surged by 81.24% to $724165.0 in 2019, then decreased by 8.24% to $664468.0 in 2020.
  • Its Total Liabilities stands at $664468.0 for Q3 2020, versus $648148.0 for Q2 2020 and $443520.0 for Q1 2020.